No Data
No Data
Cencora (NYSE:COR) Ticks All The Boxes When It Comes To Earnings Growth
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit.
Citi Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $280
Citi analyst Daniel Grosslight maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $280.According to TipRanks data, the analyst has a success rate of 50.4% and a total
Insider Sale: Steven Collis Sells 10,755 Shares of Cencora Inc (COR)
McKesson, Cardinal, Cencora Interested in Buying Private Cancer Clinics - Report
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 8.06% on an annualized basis producing an average annual return of 21.25%. Currently, Cencora has a market capitalization of $44
Why Cencora (COR) Is a Top Value Stock for the Long-Term